DMAB
Live / Applied — Second extension granted (statement of use) (as of 03 Dec 2025)
What this means for you
Not registered yet, but its 14 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97632191
- Mark type
- Stylized text
- Filed
- 14 Oct 2022
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations comprising nucleic acid encoded monoclonal antibody proteins produced in vivo for the treatment of cancers, genetic disorders, infectious diseases, and chronic diseases
Owner
- Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, US
- Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, US
Prosecution history
- 04 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Dec 2025 — SOU EXTENSION 2 GRANTED
- 03 Dec 2025 — SOU EXTENSION 2 FILED
- 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2025 — SOU EXTENSION 1 GRANTED
- 03 Jun 2025 — SOU EXTENSION 1 FILED
- 03 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2024 — PUBLISHED FOR OPPOSITION
- 02 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Sept 2024 — EXAMINER'S AMENDMENT ENTERED
- 16 Sept 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED